Bristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks With AstraZeneca - Barron's
business 2026/08/03 18:16:00

Bristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks With AstraZeneca - Barron's

Source:Barron's
Author:George Glover, Mackenzie Tatananni

A merger between Bristol Myers Squibb and AstraZeneca would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of Friday’s close, while Bristol Myers Squibb had a total valuation of $133 billion.